Bard Financial Services, Inc. Novo Nordisk A S Transaction History

Bard Financial Services, Inc.

$801 Million
Q1 2025

A detailed history of Bard Financial Services, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Bard Financial Services, Inc. holds 81,765 shares of NVO stock, worth $5.43 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares

81,765

Previous 85,390 4.25%

Holding current value

$5.43 Million

Previous $7.35 Million 22.71%

% of portfolio

0.71%

Previous 0.9%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 15, 2025	SELL	$69.3 - $90.95 $251,212 - $329,693	-3,625 Reduced 4.25%	81,765 $5.68 Million
Q4 2024 Jan 06, 2025	SELL	$85.0 - $120.04 $297,500 - $420,140	-3,500 Reduced 3.94%	85,390 $7.35 Million
Q3 2024 Nov 20, 2024	BUY	$119.07 - $145.42 $8.12 Million - $9.92 Million	68,225 Added 330.15%	88,890 $10.6 Million
Q3 2024 Oct 04, 2024	SELL	$119.07 - $145.42 $9.11 Million - $11.1 Million	-76,500 Reduced 78.73%	20,665 $2.46 Million
Q2 2024 Jul 09, 2024	BUY	$122.71 - $146.91 $277,324 - $332,016	2,260 Added 2.38%	97,165 $13.9 Million
Q1 2024 May 06, 2024	SELL	$102.11 - $135.92 $252,722 - $336,401	-2,475 Reduced 2.54%	94,905 $12.2 Million
Q4 2023 Feb 09, 2024	BUY	$87.78 - $105.45 $234,372 - $281,551	2,670 Added 2.82%	97,380 $10.1 Million
Q3 2023 Oct 16, 2023	BUY	$90.94 - $199.54 $4.14 Million - $9.09 Million	45,555 Added 92.68%	94,710 $8.61 Million
Q2 2023 Jul 11, 2023	SELL	$155.98 - $172.65 $257,366 - $284,872	-1,650 Reduced 3.25%	49,155 $7.95 Million
Q1 2023 Apr 26, 2023	SELL	$132.34 - $159.14 $198,510 - $238,709	-1,500 Reduced 2.87%	50,805 $8.09 Million
Q4 2022 Jan 25, 2023	SELL	$102.55 - $135.33 $89,731 - $118,413	-875 Reduced 1.65%	52,305 $7.08 Million
Q3 2022 Oct 26, 2022	BUY	$95.28 - $116.93 $23,820 - $29,232	250 Added 0.47%	53,180 $5.3 Million
Q2 2022 Jul 06, 2022	SELL	$103.24 - $121.81 $12,905 - $15,226	-125 Reduced 0.24%	52,930 $5.9 Million
Q1 2022 Apr 13, 2022	SELL	$93.1 - $112.54 $46,550 - $56,270	-500 Reduced 0.93%	53,055 $5.89 Million
Q4 2021 Jan 24, 2022	SELL	$95.88 - $117.08 $19,176 - $23,416	-200 Reduced 0.37%	53,555 $6 Million
Q3 2021 Oct 15, 2021	SELL	$84.42 - $106.62 $8,442 - $10,662	-100 Reduced 0.19%	53,755 $5.16 Million
Q2 2021 Jul 13, 2021	SELL	$67.66 - $84.76 $42,287 - $52,975	-625 Reduced 1.15%	53,855 $4.51 Million
Q1 2021 May 14, 2021	SELL	$67.06 - $75.82 $368,830 - $417,009	-5,500 Reduced 9.17%	54,480 $3.67 Million
Q4 2020 Mar 26, 2021	BUY	$63.89 - $73.8 $3.83 Million - $4.43 Million	59,980 New	59,980 $4.19 Million

Others Institutions Holding NVO

# of Institutions

1,846

Shares Held

340M

Call Options Held

12M

Put Options Held

10.6M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $150B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bard Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bard Financial Services, Inc. with notifications on news.

Account

Bard Financial Services, Inc. Novo Nordisk A S Transaction History